Literature DB >> 2102668

The effect of prescribed daily dose frequency on patient medication compliance.

S A Eisen1, D K Miller, R S Woodward, E Spitznagel, T R Przybeck.   

Abstract

The objective of this study was to determine the relationship between prescribed daily dose frequency and patient medication compliance. The medication compliance of 105 patients receiving antihypertensive medications was monitored by analyzing data obtained from special pill containers that electronically record the date and time of medication removal. Inaccurate compliance estimates derived using the simple pill count method were thereby avoided. Compliance was defined as the percent of days during which the prescribed number of doses were removed. Compliance improved from 59.0% on a three-time daily regimen to 83.6% on a once-daily regimen. Thus, compliance improves dramatically as prescribed dose frequency decreases. Probably the single most important action that health care providers can take to improve compliance is to select medications that permit the lowest daily prescribed dose frequency.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2102668

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  143 in total

Review 1.  Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence?

Authors:  K A Payne; S Esmonde-White
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

Review 2.  Pharmacoeconomics of hypertension management: the place of combination therapy.

Authors:  E Ambrosioni
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 3.  Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril.

Authors:  Claudio Borghi; Arrigo F G Cicero
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

Review 4.  Is fixed combination therapy appropriate for initial hypertension treatment?

Authors:  William J Elliott
Journal:  Curr Hypertens Rep       Date:  2002-08       Impact factor: 5.369

5.  Drug delivery systems for treatment of systemic hypertension.

Authors:  L Michael Prisant; William J Elliott
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 6.  Under-prescribing and non-adherence to medications after coronary bypass surgery in older adults: strategies to improve adherence.

Authors:  David Sengstock; Peter Vaitkevicius; Ahmed Salama; Robert M Mentzer
Journal:  Drugs Aging       Date:  2012-02-01       Impact factor: 3.923

7.  Pharmaceutical formulation and healthcare expenditures.

Authors:  D A Sclar; T L Skaer
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

8.  Epidemiology and pharmacoeconomic issues relating to acute respiratory tract infections and acute uncomplicated infections of the urinary tract.

Authors:  N M Graham
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

Review 9.  Noncompliance with antihypertensive therapy. Economic consequences.

Authors:  T L Skaer; D A Sclar; L M Robison
Journal:  Pharmacoeconomics       Date:  1996-01       Impact factor: 4.981

10.  Cost considerations in the drug treatment of hypertension. Is older better?

Authors:  N M Kaplan
Journal:  Pharmacoeconomics       Date:  1996-04       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.